Home » WITH MS DRUG STATUS IN LIMBO, FIRMS WORK ON PATIENT CONFIDENCE
WITH MS DRUG STATUS IN LIMBO, FIRMS WORK ON PATIENT CONFIDENCE
It was barely two hours after a panel recommended to the Food and Drug Administration that it allow the drug Tysabri back on the market when Dr. Joseph Berger got an e-mail inviting him to a special class.
The
Star-Telegram
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May